Intact Vascular Tack Endovascular System, to treat vascular dissections with Tack implant(s) foll...
FDA Device Recall #Z-1070-2025 — Class I — January 10, 2025
Recall Summary
| Recall Number | Z-1070-2025 |
| Classification | Class I — Serious risk |
| Date Initiated | January 10, 2025 |
| Status | Ongoing |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Spectranetics Corporation |
| Location | Colorado Springs, CO |
| Product Type | Devices |
| Quantity | 2,939 |
Product Description
Intact Vascular Tack Endovascular System, to treat vascular dissections with Tack implant(s) following angioplasty: (4F,1.5-4.5mm), 150cm, REF: 154150041; Tack, 4F Gen 1.5, 150cm CE, REF: 154150042; Tack, 4F Gen 1.5, 90cm CE, REF: 154090042 (6F, 3.5 - 6.0mm), 135cm, REF: 156135061; (6F, 4.0 - 8.0mm), 135cm, REF: 206135061; Tack, 6F Gen 2.0, 135cm CE, REF: 206135062; Tack, 6F Gen 1.5, 135cm CE, REF: 156135062; Tack, 6F Gen 2.0, 80cm CE, REF: 206080062; Tack, 6F Gen 1.5, 80cm CE, REF: 156080062
Reason for Recall
Use of Tack Endovascular system, designed to treat acute dissections of inner wall or lining of an artery by tacking damaged tissue to inner luminal surface, could result in problems with deployment and stability of device in vessel after deployment, which may cause failure to resolve dissection, migration of implant, bailout stenting, reintervention, unintended removal of tack devices, and ischemia.
Distribution Pattern
Distribution US nationwide and countries of: NL, DE, NL, AU, IT, CH, GB, and AT
Lot / Code Information
UDI-DI: REF/UDI-DI/Batch: 154150041/00863328000189/332905 - 349049, 154150042/328641, REF: 154090042/322101, 156135061/00863328000103/332824 - 336121, 206135061/00850003494043/331281 - 336152, 206135062/328643 - 345567, 156135062/271330 - 283066, 206080062/321083 - 349035, 156080062/302251 - 349034
Other Recalls from Spectranetics Corporation
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-0680-2025 | Class II | Turbo Elite Laser Atherectomy Catheter Model N... | Nov 25, 2024 |
| Z-0509-2024 | Class II | Spectranetics Turbo-Elite Laser Atherectomy Cat... | Nov 15, 2023 |
| Z-0221-2023 | Class II | Philips Laser System, REF: LAS-100. Used in mi... | Oct 14, 2022 |
| Z-1351-2022 | Class II | Philips Laser System, REF LAS-100, Intermittent... | Jun 1, 2022 |
| Z-2143-2020 | Class II | Bridge Occlusion Balloon, REF 590-001, QTY 1, S... | Mar 31, 2020 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.